Getlabs to Add GRAIL’s Multi-Cancer Early Detection Test for Home Diagnostic Services
By analyzing fragments of cfDNA in a simple blood draw, the Galleri test can screen for many deadly cancers.
Read More
Search Results for: Grail
GRAIL’s Multi-Cancer Early Detection Test Gets Added to Insurance Plan
Galleri can identify DNA shed by cancer cells to help screen for some of the deadliest cancers that don’t have recommended screening today.
Read More
Illumina Announces Divestiture of GRAIL
Illumina will divest GRAIL after a federal appeals court upheld an FTC ruling that it should unwind its deal with GRAIL.
Read More
GRAIL Study To Evaluate Multi-Cancer Early Detection Test for Medicare Population
The study will assess the clinical impact of the Galleri test in addition to recommended cancer screenings in the Medicare population.
Read More
Participants Named for GRAIL’s Second Multi-Cancer Screening Blood Trial
The University of Illinois Chicago will participate in a study of a test that screens for a shared cancer signal in patient blood samples.
Read More